Related Experiment Video
Updated: Dec 29, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Genes frequently associated with sudden death in primary hypertrophic cardiomyopathy
Diana L Herrera-Rodríguez1, Armando Totomoch-Serra2,3, Sandra Rosas-Madrigal4
1Servicios de Salud de Chihuahua, Secretaría de Salud, Chihuahua, México.
Insights
Hypertrophic cardiomyopathy (HCM) is a genetic heart disease causing thickened ventricles. Mutations in sarcomere genes, particularly MYBPC3 and MYH7, are strongly linked to sudden cardiac death in affected individuals.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Hypertrophic cardiomyopathy (HCM) is defined by left ventricular hypertrophy without other cardiac or systemic causes.
- Sudden cardiac death can be the initial clinical presentation of HCM.
- While prevalent in adulthood, HCM also affects children and adolescents, often with a strong genetic basis.
Purpose of the Study:
- To elucidate the Mendelian inheritance patterns of hypertrophic cardiomyopathy.
- To identify key genes associated with sudden cardiac death in HCM.
- To discuss the role of sarcomeric proteins in the pathogenesis of HCM.
Main Methods:
- Review of genetic databases and literature on inherited cardiomyopathies.
- Analysis of gene mutations associated with autosomal dominant inheritance.
- Focus on sarcomere protein-encoding genes, particularly those in the thick filament.
Main Results:
- Primary (familial) HCM follows an autosomal dominant inheritance pattern.
- Mutations in sarcomere proteins are implicated, with thick filament proteins frequently affected.
- The MYBPC3 and MYH7 genes are most strongly associated with sudden cardiac death in HCM patients.
Conclusions:
- Understanding the Mendelian inheritance of HCM is crucial for genetic counseling and risk stratification.
- Mutations in MYBPC3 and MYH7 significantly increase the risk of sudden cardiac death in hypertrophic cardiomyopathy.
- Targeting sarcomere gene mutations offers potential for improved diagnostics and therapeutics in HCM.
Abstract:
Hypertrophic cardiomyopathy is characterized by left ventricular hypertrophy without apparent cardiac justification. Sudden cardiac death may be the first manifestation of the disease. It occurs mainly in adulthood and can be seen in childhood and adolescence where genetic origin predominates. Primary HCM ("familial") is inherited in an autosomal dominant pattern in the 25 subtypes informed in Online Mendelian Inheritance in Man. The proteins encoded by the mutated genes are part of the sarcomere in the cardiac cells, being the thick filament the most frequently affected, with the worst prognosis. In the present article, we describe the Mendelian inheritance of the disease and the two most associated genes with sudden death: MYBPC3 and MYH7.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Mechanism of Cardiac Arrhythmias
Myocarditis I: Introduction

